Australian Clinical Labs Limited

ASX:ACL Stock Report

Market Cap: AU$682.4m

Australian Clinical Labs Management

Management criteria checks 3/4

Australian Clinical Labs' CEO is Melinda McGrath, appointed in Dec 2020, has a tenure of 3.92 years. total yearly compensation is A$1.56M, comprised of 55.9% salary and 44.1% bonuses, including company stock and options. directly owns 1.09% of the company’s shares, worth A$7.43M. The average tenure of the management team and the board of directors is 5.4 years and 3.6 years respectively.

Key information

Melinda McGrath

Chief executive officer

AU$1.6m

Total compensation

CEO salary percentage55.9%
CEO tenure3.9yrs
CEO ownership1.1%
Management average tenure5.4yrs
Board average tenure3.6yrs

Recent management updates

Recent updates

Why Investors Shouldn't Be Surprised By Australian Clinical Labs Limited's (ASX:ACL) 29% Share Price Surge

Sep 03
Why Investors Shouldn't Be Surprised By Australian Clinical Labs Limited's (ASX:ACL) 29% Share Price Surge

Should You Think About Buying Australian Clinical Labs Limited (ASX:ACL) Now?

Sep 02
Should You Think About Buying Australian Clinical Labs Limited (ASX:ACL) Now?

We Think Australian Clinical Labs (ASX:ACL) Is Taking Some Risk With Its Debt

Jun 20
We Think Australian Clinical Labs (ASX:ACL) Is Taking Some Risk With Its Debt

Are Investors Undervaluing Australian Clinical Labs Limited (ASX:ACL) By 46%?

Feb 21
Are Investors Undervaluing Australian Clinical Labs Limited (ASX:ACL) By 46%?

Is It Time To Consider Buying Australian Clinical Labs Limited (ASX:ACL)?

Dec 08
Is It Time To Consider Buying Australian Clinical Labs Limited (ASX:ACL)?

Here's Why We Think Australian Clinical Labs (ASX:ACL) Might Deserve Your Attention Today

Aug 14
Here's Why We Think Australian Clinical Labs (ASX:ACL) Might Deserve Your Attention Today

Australian Clinical Labs Limited (ASX:ACL) Just Reported Half-Year Earnings: Have Analysts Changed Their Mind On The Stock?

Feb 25
Australian Clinical Labs Limited (ASX:ACL) Just Reported Half-Year Earnings: Have Analysts Changed Their Mind On The Stock?

New Forecasts: Here's What Analysts Think The Future Holds For Australian Clinical Labs Limited (ASX:ACL)

Dec 22
New Forecasts: Here's What Analysts Think The Future Holds For Australian Clinical Labs Limited (ASX:ACL)

The Market Lifts Australian Clinical Labs Limited (ASX:ACL) Shares 31% But It Can Do More

Dec 21
The Market Lifts Australian Clinical Labs Limited (ASX:ACL) Shares 31% But It Can Do More

The Strong Earnings Posted By Australian Clinical Labs (ASX:ACL) Are A Good Indication Of The Strength Of The Business

Sep 01
The Strong Earnings Posted By Australian Clinical Labs (ASX:ACL) Are A Good Indication Of The Strength Of The Business

CEO Compensation Analysis

How has Melinda McGrath's remuneration changed compared to Australian Clinical Labs's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024AU$2mAU$873k

AU$24m

Mar 31 2024n/an/a

AU$20m

Dec 31 2023n/an/a

AU$15m

Sep 30 2023n/an/a

AU$26m

Jun 30 2023AU$1mAU$873k

AU$36m

Mar 31 2023n/an/a

AU$55m

Dec 31 2022n/an/a

AU$73m

Sep 30 2022n/an/a

AU$126m

Jun 30 2022AU$2mAU$873k

AU$178m

Mar 31 2022n/an/a

AU$156m

Dec 31 2021n/an/a

AU$134m

Sep 30 2021n/an/a

AU$97m

Jun 30 2021AU$2mAU$875k

AU$60m

Mar 31 2021n/an/a

AU$79m

Dec 31 2020n/an/a

AU$98m

Sep 30 2020n/an/a

AU$70m

Jun 30 2020AU$2mAU$852k

AU$41m

Compensation vs Market: Melinda's total compensation ($USD1.01M) is about average for companies of similar size in the Australian market ($USD910.58K).

Compensation vs Earnings: Melinda's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.

CEO

Melinda McGrath

3.9yrs

Tenure

AU$1,560,335

Compensation

Ms. Melinda McGrath is Chief Executive Officer and Executive Director at Australian Clinical Labs Limited since December 19, 2020. She served as Chief Executive Officer and Executive Director at Clinical L...

Leadership Team

NamePositionTenureCompensationOwnership
Melinda McGrath
CEO & Executive Director3.9yrsAU$1.56m1.09%
A$ 7.4m
Darren McKee
Chief Executive Officer of Victoria1.8yrsAU$37.27kno data
Matthew Cordingley
Chief Financial Officerless than a yearno datano data
Anthony Friedli
Chief Operating Officer8.8yrsno data0%
A$ 0
Sean Jackson
Chief Information Officer9.8yrsno datano data
Joe Geran
National Marketing Directorno datano datano data
Tony Landgren
National Medical Director & Chief Pathologist15.8yrsno data0%
A$ 0
Chris Brownlow
Chief Executive Officer of New South Wales & Australian Capital Territory13.8yrsno datano data
Shae Seymour
Chief Executive Officer of WA/SA/NT6.8yrsno datano data
Eleanor Padman
Company Secretary3.6yrsno datano data
Rob Izzard
Chief Executive Officer of ACL Commercial Pathology1.8yrsno datano data

5.4yrs

Average Tenure

Experienced Management: ACL's management team is seasoned and experienced (5.4 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Melinda McGrath
CEO & Executive Director3.9yrsAU$1.56m1.09%
A$ 7.4m
Michael Alscher
Non-Executive Chairman1.2yrsAU$152.73k0.14%
A$ 958.1k
Christine Bartlett
Independent Non-Executive Director1.3yrsAU$111.74k0.010%
A$ 68.3k
Leanne Rowe
Independent Non-Executive Director3.6yrsAU$131.18k0.0025%
A$ 17.1k
Mark Haberlin
Independent Non-Executive Director3.6yrsAU$136.23k0.024%
A$ 162.3k

3.6yrs

Average Tenure

61yo

Average Age

Experienced Board: ACL's board of directors are considered experienced (3.6 years average tenure).